‹‹58››. Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview.
‹‹59››. Pasche B, Wang M, Pennison M, Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand?
‹‹60››. Karnezis T, Shayan R, Fox S, Achen MG, Stacker SA. The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.
‹‹61››. Macdonald S. Aspirin use to be banned in under 16 year olds.
‹‹62››. Siller-Matula JM. Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice?
‹‹63››. Sutcliffe P, Connock M, Gurung T, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials.
‹‹64››. Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention.
‹‹65››. McCarty MF. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention.
‹‹66››. Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention.
‹‹67››. Paterson JR, Blacklock C, Campbell G, Wiles D, Lawrence JR. The identifi cation of salicylates as normal constituents of serum: a link between diet and health?
‹‹68››. Rinelli S, Spadafranca A, Fiorillo G, Cocucci M, Bertoli S, Battezzati A. Circulating salicylic acid and metabolic and inflammatory responses after fruit ingestion.
‹‹69››. Blacklock CJ, Lawrence JR, Wiles D, et al. Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin.
‹‹70››. Knutsen SF. Lifestyle and the use of health ser vices.
‹‹71››. McCarty MF. Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin.
‹‹72››. Willcox BJ, Willcox DC, Todoriki H, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world’s longest-lived people and its potential impact on morbidity and life span.
‹‹73››. McCarty MF. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention.
‹‹74››. Paterson JR, Srivastava R, Baxter GJ, Graham AB, Lawrence JR. Salicylic acid content of spices and its implications.
‹‹75››. Paterson JR, Srivastava R, Baxter GJ, Graham AB, Lawrence JR. Salicylic acid content of spices and its implications.
‹‹76››. Pasche B, Wang M, Pennison M, Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand?
‹‹77››. Paterson JR, Srivastava R, Baxter GJ, Graham AB, Lawrence JR. Salicylic acid content of spices and its implications.